Showing 1–12 of 46 results

  • Placeholder

    6-MP (Mercaptopurine)

    0 out of 5
    Price range: $50 through $95

    6‑MP (6‑Mercaptopurine) is an oral chemotherapy agent and purine analog that interferes with DNA and RNA synthesis. It’s commonly used in acute lymphoblastic leukemia (ALL), Crohn’s disease maintenance, and other hematologic disorders under strict medical monitoring to help induce and maintain remission.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Alphalan (Melphalan)

    0 out of 5
    Price range: $142 through $325

    Alphalan is an oral tablet containing prednisolone, a potent systemic corticosteroid. It effectively reduces inflammation, suppresses immune responses, and treats conditions such as asthma exacerbations, rheumatoid arthritis, severe allergies, skin disorders, and certain autoimmune diseases under healthcare supervision.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Altraz (Anastrozole) – 1 Mg

    0 out of 5
    Price range: $56 through $135

    Altraz 1 mg is an oral tablet containing anastrozole, a potent aromatase inhibitor. By blocking estrogen production, it’s primarily used in postmenopausal women with hormone receptor-positive breast cancer, both as adjuvant therapy and for recurrence prevention following initial treatment.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Anastrozole (Anastrozole) – 1 Mg

    0 out of 5
    Price range: $49 through $139

    Anastrozole 1 mg is a non‑steroidal aromatase inhibitor widely used in the treatment and prevention of hormone receptor‑positive breast cancer in postmenopausal women. It works by inhibiting the aromatase enzyme, which reduces estrogen levels and slows tumor growth. The tablet form supports once‑daily oral dosing and is commonly administered over several years depending on treatment stage and risk factors.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Antreol (Anastrozole) – 1 Mg

    0 out of 5
    Price range: $28 through $82

    Antreol 1 mg contains anastrozole, a potent non‑steroidal aromatase inhibitor used to treat hormone receptor–positive early breast cancer in postmenopausal women, and to prevent recurrence. It works by blocking the aromatase enzyme and reducing estrogen production, thereby slowing tumor progression. This oral tablet is typically taken once daily for 5 to 10 years depending on clinical guidelines and individual risk factors.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Armotraz (Anastrozole) – 1 Mg

    0 out of 5
    Price range: $50 through $150

    Armotraz 1 mg is an oral tablet formulation of anastrozole, a selective aromatase inhibitor that blocks estrogen synthesis. It’s primarily prescribed to postmenopausal women with hormone receptor-positive breast cancer, both as adjuvant therapy and for preventing recurrence following initial treatment.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Aromasin (Exemestane) – 25 Mg

    0 out of 5
    Price range: $95 through $323

    Aromasin 25 mg is an oral tablet containing exemestane, a steroidal aromatase inhibitor that reduces estrogen production by irreversibly binding to the aromatase enzyme. It is indicated for postmenopausal women with hormone receptor‑positive early breast cancer following prior tamoxifen therapy, as well as for advanced or recurrent breast cancer. By effectively lowering estrogen levels, Aromasin helps inhibit the growth of hormone-dependent tumors

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Azel 40 Mg (Enzalutamide)

    0 out of 5
    Price range: $350 through $966

    Azel 40 mg is a targeted oral cancer treatment containing Enzalutamide, primarily prescribed for advanced or metastatic prostate cancer. It works by blocking androgen receptors and preventing the action of male hormones that fuel cancer growth. Azel is a non-chemotherapy capsule and can be used even after other treatments stop working. It’s a trusted option to help manage cancer progression and improve quality of life.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Belustine (Lomustine) – 40 Mg

    0 out of 5
    Price range: $40 through $95

    Belustine 40 mg is an oral chemotherapy capsule formulated with lomustine, a nitrosourea alkylating agent. It penetrates the blood-brain barrier, making it effective against central nervous system malignancies, such as gliomas, glioblastoma multiforme, and recurrent brain metastases. Additionally, lomustine has demonstrated efficacy in treating Hodgkin lymphoma and other tumor types when used alone or in combination regimens.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Bevatas 100 Mg Injection

    0 out of 5
    Price range: $974 through $2,786

    Bevatas 100 mg Injection is an intravenous oncology treatment containing bevacizumab, a VEGF‑targeted monoclonal antibody. It works by blocking blood vessel formation in tumors, helping to slow cancer progression and enhance effects of chemotherapy in conditions like metastatic colorectal, non‑small cell lung, renal, and ovarian cancers.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Calutide (Bicalutamide) – 50 Mg

    0 out of 5
    Price range: $59 through $161

    Calutide 50 mg is an oral tablet formulation of bicalutamide, a non-steroidal anti-androgen that inhibits androgen receptors, blocking testosterone-driven prostate cancer growth. It is commonly prescribed in combination with luteinizing hormone‑releasing hormone (LHRH) agonists for advanced prostate cancer or as monotherapy in selected cases. By antagonizing androgen effects, Calutide helps reduce tumor progression.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Placeholder

    Capegard (Capecitabine) – 500 Mg

    0 out of 5
    Price range: $285 through $930

    ✅ Key Benefits Oral administration for convenience over IV 5‑FU Tumor‑targeted action with selective activation in cancer cells Widely studied and effective across multiple solid tumors When combined with other agents (e.g., oxaliplatin, irinotecan), enhances treatment efficacy 🎯 How to Use Common regimen: 1250 mg/m² twice daily on days 1–14 of a 21-day cycle, per oncologist’s…

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content